From COVID To Flu: Tracking New Disease Variants That Emerged In 2025

Updated Dec 16, 2025 | 03:03 PM IST

SummaryA year-end look at the new disease variants that emerged in 2025, from evolving COVID strains and flu subclades to mpox and chikungunya mutations, and what health experts learned from their spread. Keep reading for details.
new variants disease of 2025

Credits: Canva

The year 2025 served as a stark reminder that COVID is no longer the only illness demanding public attention. Over the months, several diseases resurfaced or intensified, some reaching epidemic levels. In many cases, the surge was driven by new variants that altered how these illnesses spread, how severe they became, and how quickly they overwhelmed health systems.

From respiratory infections to vector-borne diseases, 2025 showed how familiar pathogens can return in unfamiliar forms. Mutations made some infections more contagious, while others blurred early symptoms, delaying diagnosis and treatment. Below, we take a look at new variants of diseases that we witnessed in 2025.

Also Read: The “Triangle of Death” on Your Face: Why You Should Never Pop a Pimple There

New Disease Variants That Emerged In 2025

COVID-19 New Variants

In 2025, fresh COVID-19 variants continued to circulate, most of them linked to Omicron sublineages. These strains spread quickly but, for many people, caused symptoms closer to a bad cold, flu, or seasonal allergies. Common symptoms included stomach issues, body pain, exhaustion, and fever.

Health authorities continued to advise testing through RAT or RT-PCR, short-term isolation, and medical care where needed. As with earlier waves, acting early made a clear difference in recovery and containment.

As per World Health Organization, some of the Covid variants that appeared in 2025 include:

XFG Variant

The XFG variant of COVID-19, also known as Stratus, surfaced in early 2025 as a recombinant strain. Recombinant variants form when two different COVID strains infect the same person and merge during mutation, a process that occurs naturally as viruses evolve. XFG drew attention because of how easily it spread and its ability to infect people despite previous infection or vaccination. Classified as a recombinant Omicron subvariant, XFG was detected widely across regions including North America, Europe, and Asia.

Also Read: 8 Red Flags That May Suggest Cancer Growth In Your Body

According to WHO-linked data from mid to late 2025:

In the United States, XFG became the leading variant, responsible for around 85 percent of reported cases by the end of September 2025.

In the United Kingdom, XFG and related sublineages accounted for a sizeable share of infections, with reports suggesting nearly 30 percent of cases in July 2025.

In India, where XFG circulated by mid-2025, early clusters were largely reported from Maharashtra, followed by Tamil Nadu, Kerala, and Gujarat. It later emerged as the dominant strain in states such as Madhya Pradesh.

The nickname “Frankenstein” was informally attached to XFG because it combines genetic material from different Omicron subvariants. Experts from institutions like the Institute Pasteur and the University of Nebraska Medical Center noted that while it spreads rapidly, it has not been linked to more severe disease.

Omicron NB.1.8.1

NB.1.8.1, informally called “Nimbus,” is a distinct Omicron lineage that was first identified in early 2025. The World Health Organization classified it as a “Variant Under Monitoring” after noticing its steady global rise, particularly across parts of Asia and North America. Although it contributed to visible spikes in case numbers, there was no strong evidence that it caused more serious illness. Vaccines continued to offer reliable protection.

By mid-2025, NB.1.8.1 had become one of the faster-spreading Omicron offshoots, driving fresh COVID waves in several countries. Despite its speed, health agencies confirmed that existing vaccines remained effective and that the variant was not linked to increased severity. The WHO officially placed it under monitoring in May 2025.

Flu New Variants

H3N2 “Subclade K” Variant

The flu strain seen during the winter months of 2025 was identified as H3N2 subclade K, a seasonal influenza A virus. Some public commentary labelled it “super flu,” though this term has no medical basis and does not suggest the virus is inherently more dangerous or resistant to treatment. A key concern was that many people had limited prior exposure to this strain, resulting in lower community immunity. Flu vaccines, however, continued to protect against severe outcomes.

Data from NHS England showed a sharp rise in flu-related hospital admissions. During the first week of December, hospitals reported an average of 2,660 flu patients per day, marking a 55 percent increase from the previous week. The number of admissions was high enough to fill more than three entire hospital trusts.

Monkeypox New Variant

Clade LB Variant

Health authorities in England detected a new mpox variant after testing a person who had recently travelled to Asia, as per BBC. Genetic sequencing revealed that the strain was recombinant, combining elements of two circulating mpox types: clade 1, which is associated with more severe illness, and clade 2, which was responsible for the 2022 global outbreak.

The UK Health Security Agency stated that it was still evaluating the implications of this strain. While most mpox cases remain mild, officials advised people who qualify for vaccination to get immunised as a precautionary step.

Chikungunya New Variant

In 2025, Chikungunya did not see the emergence of a single newly named variant. Instead, there was a renewed spread of the East, Central, and South African genotype, particularly the Indian Ocean Lineage. This lineage has developed mutations that improve its ability to spread.

According to the National Institutes of Health, certain CHIKV lineages, including the E1-226A variant, previously helped shift infections into urban settings. More recent severe cases reported in India, including outbreaks in Pune in 2024, showed signs of neurological involvement such as paralysis and darkened nasal tissue. These symptoms are thought to be linked to mutations like E1-226V or A and E2-I211T, along with improved adaptation of the virus to Aedes aegypti mosquitoes, pointing to continued viral evolution aimed at more efficient transmission.

End of Article

Shift to Plant-Based Proteins, Low-Fat Dairy To Boost Heart Health: American Heart Association

Updated Apr 1, 2026 | 06:00 PM IST

SummaryThe nutrition guidance emphasizes a diet rich in vegetables, fruits, and whole grains with less sugar, salt, and ultra-processed foods. It also prioritizes protein from plant-based sources and urges the use of low-fat dairy products.
Shift to Plant-Based Proteins, Low-Fat Dairy To Boost Heart Health: American Heart Association

Credit: iStock

The American Heart Association (AHA), in its latest update on nutrition guidance, has urged the need to eat a diet rich in vegetables and fruits, while also making a key shift to plant-based protein from meat-based protein earlier to improve heart health.

It has also emphasized the need to reduce the intake of sugar, salt and ultra-processed foods, as well as to switch to low-fat dairy.

The scientific statement, which is issued about every five years, comes amid increasing cases of high blood pressure and obesity in the US, which can potentially lead to poor health outcomes, including deaths from cardiovascular disease and other chronic conditions.

“For healthy eating to be more attainable and sustainable, we recommend people focus on their overall eating pattern rather than specific nutrients or foods. This approach is actionable, something that can be modified as people pass through different life stages, while still adhering to the nine key features,” said Alice H. Lichtenstein, volunteer chair of the scientific statement writing committee and senior scientist.

“The guidance applies to wherever you eat: at home, school, work, restaurants, or in your community. You want to strive for progress rather than perfection. Every time you choose to make a swap for a healthier alternative, you’re making a step toward a healthier life,” added Lichtenstein, who is also senior scientist at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Boston.

The 9 Guidelines for a heart-healthy dietary pattern include:

  • Maintaining a healthy body weight by balancing food intake and physical activity
  • Eating plenty of vegetables and fruits
  • Choose whole grains such as whole‑wheat bread, brown rice, and oatmeal over refined grains such as white bread or white rice
  • Shifting from meat to plant-based sources such as legumes, including beans, peas, and lentils, along with nuts and seeds, and fish and seafood. Select low-fat or fat-free dairy products.
  • Replace saturated fats with healthy unsaturated fats, including those from nuts, seeds, avocados, and non-tropical plant oils.
  • Choose minimally processed foods instead of ultra-processed foods
  • Limit beverages and foods with added sugars
  • Choose foods low in sodium and prepare foods with minimal or no salt
  • Limit intake of alcohol

Shift to Plant-Based Proteins, Low-Fat Dairy To Boost Heart Health: American Heart Association

Also read: AHA’s New Dyslipidemia Guidelines Stress Early Screening, Lifestyle Management

Healthy Eating Patterns From Childhood

The 2026 guidance for children recommends a heart‑healthy dietary pattern starting at 1 year of age. It urges families to play a significant role and become role models.

“Cardiovascular disease begins early in life; even prenatal factors can contribute to increased risk in children as they grow. So, it’s important that healthy eating patterns are adopted in childhood and continue throughout the entire lifespan,” Lichtenstein said.

“The best way to do that is for adults to role model heart-healthy eating patterns inside and outside the home,” she added.

Also read: Cardiovascular Diseases Lead As India’s Top Killer: US Cardiologist Points Out Risk Factors

While the updated guidance is specifically designed to improve cardiovascular health, it may also help improve other conditions like type 2 diabetes, kidney disease, some cancers, and brain health.

End of Article

Breast Conservation Surgery vs Mastectomy: What Surgeons Recommend Today

Updated Apr 1, 2026 | 02:57 PM IST

Summary​The debate between breast conservation surgery and mastectomy is no longer about which is superior, but about which is most appropriate for the individual patient.
Breast Conservation Surgery vs Mastectomy: What Surgeons Recommend Today

Credit: Freepik

Breast cancer treatment has evolved significantly over the past few decades, moving from radical removal approaches to more personalized and tissue-preserving techniques. Today, surgeons no longer view breast conservation surgery (BCS) and mastectomy as competing options, but as equally effective strategies chosen based on individual patient needs.

With the growing availability of reconstructive surgery in Kolkata, patients now also have better cosmetic and psychological outcomes regardless of the surgical path they choose.

Understanding The Two Surgical Options

When faced with a breast cancer diagnosis, understanding the available surgical options is crucial for making an informed decision. Each approach is designed to effectively treat the disease while considering the patient’s long-term health, comfort, and quality of life.

What Is Breast Conservation Surgery (BCS)?

Breast conservation surgery, or lumpectomy or partial mastectomy, is a procedure that involves the removal of the tumor and a small amount of surrounding healthy tissue while preserving most of the breast.

The main objective is to remove cancer without altering the natural shape and appearance of the breast. Radiation therapy is usually administered after surgery to kill any remaining cancer cells and minimize the chances of recurrence.

What Is A Mastectomy?

Mastectomy is the removal of the whole breast tissue, and in other cases, the lymph nodes and skin around the breast. It can be done on either breast or both breasts based on the type of cancer and risk factors.

After a mastectomy, patients can choose to have breast reconstruction with the help of modern surgical procedures, such as those provided in reconstructive surgery in Kolkata, which can help to restore the shape and symmetry of the breast.

Major Differences Between BCS And Mastectomy

The basic distinction is the degree of tissue excision. BCS leaves the majority of the breast, but a mastectomy takes away all of it.

FactorBreast Conservation Surgery (BCS)Mastectomy
Extent of SurgeryRemoves tumor with a small margin of healthy tissueRemoves entire breast tissue
InvasivenessLess invasiveMore extensive surgery
Cosmetic OutcomePreserves most of the natural breast shapeThe breast is removed (reconstruction may be needed)
Recovery TimeGenerally faster recoveryLonger recovery period
Radiation TherapyUsually required after surgeryMay or may not be required
Risk of RecurrenceSlightly higher local recurrence riskLower local recurrence risk
Hospital StayOften shorter or a day-care procedureMay require a longer hospital stay
SuitabilityEarly-stage cancer, smaller tumorsLarger tumors, multiple areas, or high-risk cases
Impact on Body ImageBetter preservation of body imageMay impact body image (can be improved with reconstruction)

Notably, several studies indicate that both methods have equal chances of survival in the long term in early-stage breast cancer.

Eligibility Criteria: Who Can Opt For What?

Not every patient is suited for the same surgical approach, as the choice largely depends on individual clinical factors. Tumor size, stage, location, and overall health all play a crucial role in determining eligibility. Understanding who can opt for which procedure helps ensure both effective treatment and optimal long-term outcomes.

Candidates for Breast Conservation Surgery

BCS is usually prescribed to patients with:

  • Stage I or II breast cancer
  • Tumors smaller than 5 cm
  • One tumor in one area
  • No radiation therapy contraindications
  • Some cases do not have high-risk genetic mutations like BRCA

It might not apply to patients who have more than one tumor in other parts of the breast or those with advanced disease.

Candidates for Mastectomy

Mastectomy may be suggested when:

  • The tumor is huge in comparison with the size of the breast
  • It has several tumors in various quadrants
  • Cancer is metastatic (Stage III or IV)
  • The genetic risk of recurrence is high in the patient
  • Radiation therapy is not an option or choice

Moreover, other patients might opt to undergo mastectomy to have a sense of security or to alleviate the fear of recurrence.

Advancements In Breast Surgery

The current surgical advances have greatly enhanced the results, particularly in patients who want to preserve their breasts.

Oncoplastic Surgery

Among the most remarkable developments is the oncoplastic breast surgery that involves the use of both cancer resection and plastic surgery. This enables the surgeons to excise bigger tumors without altering the shape and symmetry of the breast.

This has increased the eligibility of BCS so that more women can avoid mastectomy and still have safe control of cancer.

Improved Imaging and Targeting

Modern imaging techniques have assisted surgeons in accurately identifying tumors so that they can be fully removed without damaging normal tissue. This enhances cosmetic outcomes as well as oncological safety.

Advanced Reconstruction Methods

The emergence of reconstructive surgery in Kolkata has given patients who have undergone mastectomy the opportunity to have an immediate or delayed reconstruction with the help of implants or autologous tissue.

Reconstruction has been brought to improve psychological well-being, body image, and quality of life.

Influencing Factors of Surgical Decision-Making

The decision to use BCS or mastectomy is not only a medical choice, but a very personal one, which depends on several factors:

1. Cancer Stage and Tumor Characteristics

The main determinants include tumor size, location, and spread. BCS is more appropriate in early-stage cancers, whereas mastectomy is usually necessary in advanced cases.

2. Survival and Recurrence Outcomes

It has always been demonstrated that the survival rates are the same with BCS (including radiation) and mastectomy in the case of early-stage cancers. Nevertheless, BCS can be slightly more likely to recur locally, which can be treated.

3. Patient Preference

A major role is played by emotional and psychological factors. There are those patients who want to keep their breasts, and others opt to undergo a mastectomy to have peace of mind. Studies show fear of recurrence is a major driver for choosing mastectomy.

4. Access to Radiation Therapy

Since BCS requires post-operative radiation, access to treatment facilities can influence the decision. Patients without easy access may opt for a mastectomy.

5. Cosmetic and Quality-of-Life Concerns

BCS tends to provide superior cosmetic results and satisfaction. Nevertheless, the modern methods of reconstruction have also helped to enhance the results of mastectomy patients considerably.

What Do Surgeons Recommend Today?

Modern breast surgeons support a multidisciplinary patient-centered approach. Instead of prescribing a single solution, they consider:

  • Clinical (tumor size, stage, genetics)
  • Access to care and patient lifestyle
  • Motivational preparedness and individual interests

Surgeons are increasingly preferring breast conservation surgery in most of the early-stage cases because of its good results and quality-of-life advantages. Nevertheless, mastectomy is necessary in more complicated or risky cases.

Conclusion

The debate between breast conservation surgery and mastectomy is no longer about which is superior, but about which is most appropriate for the individual patient. Oncoplastic techniques and reconstructive surgery in Kolkata have advanced, and patients now have a choice of safer, more personalized, and cosmetically satisfying options.

End of Article

The New Era of Cardiac Care: How Advanced Transplant Techniques are Saving Lives in India

Updated Apr 1, 2026 | 08:38 AM IST

SummaryData from the National Organ and Tissue Transplant Organization (NOTTO) shows a significant year-on-year rise in heart transplants, with 253 transplants done in 2024.
The New Era of Cardiac Care: How Advanced Transplant Techniques are Saving Lives in India

Credit: Canva

Heart failure has quietly emerged as one of India’s most serious and underestimated health challenges, driven by a rise in hypertension, diabetes, obesity, and delayed diagnosis of heart disease.

Due to a shortage of donor organs and a long waiting period before receiving the right treatment, end-stage heart failure patients in India faced a lot of difficulties a few years ago.

Today, advancements in heart transplant techniques are changing the situation from what was once an untreatable condition to a second chance at life.

Data from the National Organ and Tissue Transplant Organization (NOTTO) shows a significant year-on-year rise in heart transplants, with 253 transplants done in 2024, showcasing improved organ donation awareness, better coordination between hospitals, and stronger transplant networks.

What was once considered the only option is now emerging as a life-saving solution, offering patients not just a second chance but a return to a more meaningful and active life.

Why Are Heart Transplants Needed?

A heart transplant offers hope and gives a second life to patients whose hearts no longer support the body even after the best available medical aid.

Although it is never performed instantly, it becomes necessary whenever conditions of the heart result in end-stage heart failure, where the pumping function of the heart is compromised.

Also read: Harish Rana’s Family Donated His Heart Valves And Corneas After His Death From Passive Euthanasia

When medications and modern technologies cannot supply an adequate amount of blood and oxygen to the organs, patients experience extreme breathlessness, fluid buildup, fatigue, and repeated hospitalizations, making even simple activities like walking, eating, or lying flat exhausting.

As the flow of blood continues to deteriorate, failure is also expected in other vital organs such as the kidneys and liver. It is at this point that the transplantation of the donor heart is considered the only treatment option to ensure that the blood flow is normalized.

How Heart Transplantation Transforms Life?

Heart transplant is not just a surgical replacement of a failing organ, but a complete life restoration for patients with end-stage heart failure.

Its benefits include:

  • Normalizes Heart Functioning: A healthy donor heart can immediately restore normal and effective blood flow. This will reduce weakness and fatigue that makes carrying out everyday tasks rather difficult.
  • Enhances Survival Rates: Patients diagnosed with end-stage heart failure can only experience the best post-transplant survival outcomes when they undergo the transplant procedure as compared to other medical treatments.
  • Enhances Quality of Life: The patients are able to attain independence once again as they are able to walk, sleep, travel, and socialize with their families and friends.
  • Prevents Frequent Hospitalization: The successful transplant procedure prevents constant hospitalization, especially in cases with deteriorating heart failure, infections, and organ dysfunction.
  • Protects Other Vital Organs: By restoring adequate blood flow, heart transplantation helps reverse damage to the kidneys, liver, and lungs caused by prolonged heart failure
  • Permits Return to Normal Roles and Responsibilities: Patients regain their ability to work, take care of others, and carry out their daily responsibilities, which helps their emotional well-being.

End of Article